24/7 Market News Wrap 8 Jan 2024
DENVER, Colo., Jan. 8, 2024 (247marketnews.com)- 24/7 Market News covered the following companies today; Cellectar Biosciences, Inc. (NASDAQ:CLRB), Aclarion, Inc. (NASDAQ:ACON), Ardelyx (NASDAQ:ARDX), Sidus Space Inc. (NASDAQ:SIDU), NexImmune Inc. (NASDAQ:NEXI), and C4 Therapeutics Inc. (NASDAQ:CCCC).
It seemed like most of this morning’s most active listings traded much better in the premarket, like Cellectar Biosciences (NASDAQ:CLRB), which reported positive data from its CLOVER WaM pivotal study that we covered when it was trading at $3.00, up $0.29 (+10.70%), on 301K shares traded.
Cellectar Biosciences went on to hit a premarket high of $4.84, but dropped down to a premarket low of $2.83, before recovering to open the regular trading session at $3.12, after trading 7.5M premarket shares. It was able to hit a regular session high of $3.59 and closed at its previous 52-week high of $3.20, up $0.49 (+18.08%), on 31M shares traded. However, considering the chart, setup, and momentum, it was somewhat disappointing.
We also covered Aclarion’s (NASDAQ:ACON) news that it executed a strategic partnership agreement with Alphatec Spine, when Aclarion was trading at $5.05, up $1.99 (+65.03%), on 2.4M shares traded, after it pulled back from what was its premarket high of $6.81. After consolidating, it too off again and ran to a premarket high of $6.97, but only trended lower throughout the regular trading session.
A few of the listings that we covered, like Ardelyx (NASDAQ:ARDX) were able to trend higher throughout the day and close near its high of the day. We covered Ardelyx when it was trading at $6.75, up $0.59 (+9.58%), on 1.8M shares traded. Ardelyx hit $8.25, shortly before it closed at $8.18, up $2.02 (+32.79%), on 26M shares traded.
However, the day belonged to the low-float listings that we’ve consistently been covering, like four that we covered again today.
Sidus Space (NASDAQ:SIDU) opened at $12.00, hit a high of $16.75, and closed at $15.32, up $2.28 (+17.48%), on 3M shares traded.
NexImmune (NASDAQ:NEXI) opened at $6.34, hit a high of $9.44, and closed at $7.57, up $1.39 (+22.49%), on 6.3M shares traded.
C4 Therapeutics Inc. (NASDAQ:CCCC) opened at $6.26, hit a high of $6.94, and closed at $6.81, up $0.41 (+6.41%), on 9.2M shares traded.
Shattuck Labs (NASDAQ:STTK) opened at $8.26, hit a high of $9.7399, and closed at $9.50, up $1.235 (+14.94%), on 731K shares traded.
Sidus Space (NASDAQ:SIDU) is trading at $15.5355, up $2.4955 (+19.14%), on 1.3M shares traded.
CONTACT:
24/7 Market News
24/7 MARKET NEWS, INC Disclaimer
24/7 Market News (24/7MN) is a third-party publisher and online news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ, and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7 MN is not affiliated with any company written about in this release and owns no shares of stock. 24/7MN’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.
The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable.
Few succeed in the stock market. Don’t trade if you’re not able to devote the necessary time. Earmark your surplus funds that you’re prepared to lose. Assess your risk appetite and set your stops accordingly, and honor your stop losses. Always employ loss limiting strategies. Be prepared to be blindsided by hidden risks, a bad company financing or other move can turn gains into losses.
Learn technical analysis, charting, patterns, and setups. Buying at the bottom and selling at the top is a myth. The middle half of a move is the sweet spot and learn how to exit a winning position, because trying to time the exact top can turn into big losses. Trade small and take advantage of small price move strategies, like scalping.
Remove emotional and psychological biases, and consider that you’re competing against professionals who’re deploying a number of powerful stock market tools. Successful traders make more on their winners than they lose on their losers. Learn how to interpret the ECN/Level 2 data.
The stocks and strategies discussed are simply ideas only and are in no way financial advice or recommendations. The author may or may not at any time be holding securities discussed. The author may or may not enter trades in the stocks mentioned. Some positions in mentioned stocks may already be held or are being adjusted or are simply examples, ideas or discussion topics. You are always trading at your own risk.
Please go to 247marketnews.com or https://247marketnews.com/terms-disclaimer/ for further information.
Connect with 24/7 Market News:
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.